Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1958 1
1961 5
1962 3
1963 1
1965 3
1966 5
1967 3
1968 12
1969 8
1970 7
1971 11
1972 7
1973 7
1974 9
1975 5
1976 14
1977 9
1978 9
1979 22
1980 16
1981 14
1982 25
1983 24
1984 27
1985 35
1986 25
1987 37
1988 35
1989 41
1990 41
1991 38
1992 64
1993 65
1994 56
1995 55
1996 61
1997 46
1998 56
1999 55
2000 81
2001 74
2002 64
2003 81
2004 74
2005 64
2006 96
2007 96
2008 118
2009 125
2010 97
2011 121
2012 142
2013 128
2014 100
2015 107
2016 142
2017 132
2018 152
2019 185
2020 210
2021 210
2022 208
2023 174
2024 185
2025 187
2026 120

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,019 results

Results by year

Filters applied: . Clear all
Page 1
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial.
Kato K, Machida R, Ito Y, Daiko H, Ozawa S, Ogata T, Hara H, Kojima T, Abe T, Bamba T, Watanabe M, Kawakubo H, Shibuya Y, Tsubosa Y, Takegawa N, Kajiwara T, Baba H, Ueno M, Takeuchi H, Nakamura K, Kitagawa Y; JCOG1109 investigators. Kato K, et al. Among authors: kojima t. Lancet. 2024 Jul 6;404(10447):55-66. doi: 10.1016/S0140-6736(24)00745-1. Epub 2024 Jun 11. Lancet. 2024. PMID: 38876133 Clinical Trial.
Heart failure promotes multimorbidity through innate immune memory.
Nakayama Y, Fujiu K, Oshima T, Matsuda J, Sugita J, Matsubara TJ, Liu Y, Goto K, Kani K, Uchida R, Takeda N, Morita H, Xiao Y, Hayashi M, Maru Y, Hasumi E, Kojima T, Ishiguro S, Kijima Y, Yachie N, Yamazaki S, Yamamoto R, Kudo F, Nakanishi M, Iwama A, Fujiki R, Kaneda A, Ohara O, Nagai R, Manabe I, Komuro I. Nakayama Y, et al. Among authors: kojima t. Sci Immunol. 2024 May 24;9(95):eade3814. doi: 10.1126/sciimmunol.ade3814. Epub 2024 May 24. Sci Immunol. 2024. PMID: 38787963
Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma.
Oyoshi H, Du J, Sakai SA, Yamashita R, Okumura M, Motegi A, Hojo H, Nakamura M, Hirata H, Sunakawa H, Kotani D, Yano T, Kojima T, Nakamura Y, Kojima M, Suzuki A, Zenkoh J, Tsuchihara K, Akimoto T, Shibata A, Suzuki Y, Kageyama SI. Oyoshi H, et al. Among authors: kojima t. Sci Adv. 2023 Dec 15;9(50):eadh9069. doi: 10.1126/sciadv.adh9069. Epub 2023 Dec 13. Sci Adv. 2023. PMID: 38091397 Free PMC article.
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer.
Yamamoto K, Owaki Y, Nakayama I, Sakamoto N, Ishizaka M, Kadota T, Okemoto D, Matsubara Y, Miyashita Y, Kobayashi A, Okazaki U, Seguchi K, Hosokai T, Ogura T, Mishima S, Kotani D, Kawazoe A, Hashimoto T, Kuboki Y, Bando H, Kojima T, Yoshino T, Kuwata T, Ishii G, Yano T, Shitara K. Yamamoto K, et al. Among authors: kojima t. ESMO Open. 2025 Oct;10(10):105805. doi: 10.1016/j.esmoop.2025.105805. Epub 2025 Sep 30. ESMO Open. 2025. PMID: 41033281 Free PMC article.
2024 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis: Secondary publication.
Harigai M, Kaneko Y, Tanaka E, Hirata S, Kameda H, Kaneko K, Kishimoto M, Kohno M, Kojima M, Kojima T, Morinobu A, Nakajima A, Sugihara T, Fusama M, Yajima N, Yanai R, Kawahito Y. Harigai M, et al. Among authors: kojima t. Mod Rheumatol. 2025 Apr 8;35(3):387-401. doi: 10.1093/mr/roaf006. Mod Rheumatol. 2025. PMID: 39820350
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study.
Metges JP, Kato K, Sun JM, Shen L, Enzinger PC, Adenis A, Doi T, Kojima T, Li Z, Kim SB, Cho BC, Mansoor W, Li SH, Sunpaweravong P, Alsina M, Buchschacher GL Jr, Hara H, Tsuji A, Wu J, Shah S, Bhagia P, Shah MA. Metges JP, et al. Among authors: kojima t. ESMO Open. 2025 Dec;10(12):105854. doi: 10.1016/j.esmoop.2025.105854. Epub 2025 Nov 18. ESMO Open. 2025. PMID: 41259897 Free PMC article. Clinical Trial.
Clinical characterization of FGFR2b expression in patients with advanced gastric or gastroesophageal junction adenocarcinoma.
Sato S, Rhodes SL, Aoki Y, Nakayama I, Hashimoto T, Hawkins J, Yanes RE, Chang CH, Nakamura Y, Kawazoe A, Mishima S, Kotani D, Kuboki Y, Bando H, Kojima T, Yoshino S, Reading S, Honeycutt H, Finger E, Endo I, Sakamoto N, Kuwata T, Yoshino T, Shitara K. Sato S, et al. Among authors: kojima t. ESMO Open. 2025 Jul;10(7):105322. doi: 10.1016/j.esmoop.2025.105322. Epub 2025 Jun 12. ESMO Open. 2025. PMID: 40513139 Free PMC article.
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer.
Mansoor W, Joo S, Norquist JM, Kato K, Sun JM, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Sunpaweravong P, Alsina M, Goekkurt E, Suryawanshi S, Shah S, Shen L. Mansoor W, et al. Among authors: kojima t. Oncologist. 2024 Oct 3;29(10):e1324-e1335. doi: 10.1093/oncolo/oyae087. Oncologist. 2024. PMID: 38815152 Free PMC article. Clinical Trial.
First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-306.
Xu J, Kato K, Hubner R, Park SR, Kojima T, Ishihara R, Wyrwicz L, Van Cutsem E, Jimenez-Fonseca P, Wu H, Wang L, Yan S, Shi J, Kadva A, Yoon HH. Xu J, et al. Among authors: kojima t. Adv Ther. 2025 May;42(5):2269-2284. doi: 10.1007/s12325-025-03115-9. Epub 2025 Mar 13. Adv Ther. 2025. PMID: 40075024 Free PMC article.
Adverse Events Associated with Airway Management in Pediatric Anesthesia: A Prospective, Multicenter, Observational Japan Pediatric Difficult Airway in Anesthesia (J-PEDIA) Study.
Kojima T, Yamauchi Y, Watanabe F, Ichiyanagi S, Kobayashi Y, Kaiho Y, Toyama H, Kasuya S, Kuratani N, Suzuki Y; J-PEDIA study investigators. Kojima T, et al. Anesthesiology. 2025 Oct 1;143(4):835-850. doi: 10.1097/ALN.0000000000005646. Epub 2025 Jul 7. Anesthesiology. 2025. PMID: 40622860 Free PMC article.
4,019 results